Friedreich's Ataxia Recruiting Phase 2 Trials for Vatiquinone (DB11917)

Also known as: Friedreich Ataxia / Friedreich's ataxia (disorder)

IndicationStatusPhase
DBCOND0037758 (Friedreich's Ataxia)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05485987A Study of Vatiquinone for the Treatment of Participants With Friedreich AtaxiaTreatment